List of bibliographic references
Number of relevant bibliographic references: 13.
Ident. | Authors (with country if any) | Title |
---|
000305 (2016) |
Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. |
000557 (2015) |
Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. |
000900 (2013) |
Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates. |
000946 (2013) |
Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys. |
000949 (2013) |
Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di Paolo | Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia. |
000A40 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie | L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
000D30 (2010) |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di Paolo | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. |
001B09 (1990) |
M N Hassan [Canada] ; J H Thakar ; J D Grimes | Behavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents. |
001B85 (1988) |
P. Falardeau [Canada] ; S. Bouchard ; P J Bédard ; R. Boucher ; T. Di Paolo | Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. |
001B86 (1988) |
M. Guttman [Canada] ; V W Yong ; S U Kim ; D B Calne ; W R Martin ; M J Adam ; T J Ruth | Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys. |
001B91 (1988) |
E C Wolters [Canada] ; J C Kebabian ; M. Guttman ; E. Mak ; B D Pate ; D B Calne | A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys. |
001B93 (1988) |
T L Perry [Canada] ; K. Jones ; S. Hansen ; R A Wall | 2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease. |
001C36 (1985) |
R. Lewin | Parkinson's disease: an environmental cause? |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Pyridines"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i \
-Sk "Pyridines" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= indexItem
|index= Mesh.i
|clé= Pyridines
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | |